
This dataset contains supplementary material and raw data from the Study of the Effects of SGLT2 Inhibitors (SGLT2i) on Cardiovascular Consequences in Type 1 Diabetes Mellitus (T1DM). Supplementary material includes tables and figures. The raw data are the original data for outcomes associated with the high-dose and placebo groups in the RCTs that met the study's inclusion requirements. The dataset is intended to provide additional evidence for the main publication and is organised for easy access.
glycosylated haemoglobin, cardiovascular disease, sodium-glucose transporter 2 inhibitors, Type 1 diabetes mellitus, diabetic ketoacidosis acidosis
glycosylated haemoglobin, cardiovascular disease, sodium-glucose transporter 2 inhibitors, Type 1 diabetes mellitus, diabetic ketoacidosis acidosis
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
